v3.25.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash flows from operating activities:    
Net income $ 209,535 $ 236,616
Adjustments to reconcile net income to cash (used in) provided by operating activities:    
Depreciation, amortization and accretion 125,876 90,584
Share-based compensation 2,584 6,791
Deferred income taxes 4,740 (29,033)
Gain on sales of businesses, net 0 (1,115)
Other, net 8,645 (814)
Changes in operating assets and liabilities:    
Accounts receivable, trade (306,822) 17,499
Inventories (202,781) (149,470)
Government grants receivable (99,118) 281,889
Other assets (114,627) (89,610)
Income tax receivable and payable (5,928) 26,239
Accounts payable and accrued expenses (145,797) (160,939)
Deferred revenue (91,169) 37,978
Other liabilities 6,880 1,108
Net cash (used in) provided by operating activities (607,982) 267,723
Cash flows from investing activities:    
Purchases of property, plant and equipment (205,966) (413,456)
Purchases of marketable securities and restricted marketable securities (389,832) (569,446)
Proceeds from maturities of marketable securities 502,937 416,971
Other investing activities 4,652 (2,697)
Net cash used in investing activities (88,209) (568,628)
Cash flows from financing activities:    
Proceeds from borrowings under debt arrangements, net of issuance costs 92,340 105,420
Repayments of Debt (176,409) (45,771)
Payments of tax withholdings for restricted shares (15,421) (18,952)
Other financing activities (129) 0
Net cash (used in) provided by financing activities (99,619) 40,697
Effect of exchange rate changes on cash, cash equivalents, restricted cash, and restricted cash equivalents 1,607 (1,938)
Net decrease in cash, cash equivalents, restricted cash, and restricted cash equivalents (794,203) (262,146)
Cash, cash equivalents, restricted cash, and restricted cash equivalents, beginning of the period 1,638,223 1,965,069
Cash, cash equivalents, restricted cash, and restricted cash equivalents, end of the period 844,020 1,702,923
Supplemental disclosure of noncash investing and financing activities:    
Property, plant and equipment acquisitions funded by liabilities 325,717 445,963
Proceeds to be received from asset-based government grants 156,900 154,754
Acquisitions funded by contingent consideration $ 6,500 $ 18,500